Page last updated: 2024-10-25

chlorpropamide and Lupus Erythematosus, Systemic

chlorpropamide has been researched along with Lupus Erythematosus, Systemic in 1 studies

Chlorpropamide: A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277)
chlorpropamide : An N-sulfonylurea that is urea in which a hydrogen attached to one of the nitrogens is substituted by 4-chlorobenzenesulfonyl group and a hydrogen attached to the other nitrogen is substituted by propyl group. Chlorpropamide is a hypoglycaemic agent used in the treatment of type 2 (non-insulin-dependent) diabetes mellitus not responding to dietary modification.

Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
KNOX, JM1

Other Studies

1 other study available for chlorpropamide and Lupus Erythematosus, Systemic

ArticleYear
PHOTOSENSITIVITY--A COMMON PHYSICAL ALLERGY.
    Southern medical journal, 1964, Volume: 57

    Topics: 4-Aminobenzoic Acid; Aminobenzoates; Anti-Bacterial Agents; Antimalarials; Chlorothiazide; Chlorprop

1964